Authentication for anonymous data collection in...
by Jacob Birk
Read article
It is not intended for patients, healthcare professionals or others that are interested in information related to therapeutic drugs or devices used for treatment.
July 21, 2023
6 min read
Authentication for anonymous data collection in...
by Jacob Birk
Read article
April 17, 2023
8 min read
A dimensional model of sentiment for psychedeli...
by Patrick Clarke
Read article
April 14, 2023
2 min read
About the Digital Tech & Delta Team blog
by Greg Ryslik, Bob Dougherty
Read article
Bob Dougherty
Vice President of Digital Health Research
As a research scientist with a background in psychology, neuroscience, signal processing, and artificial intelligence, Bob is leading the data science and machine learning efforts aimed at improving the safety, efficacy, and scalability of psilocybin treatment.
Greg Ryslik
Chief Technology Officer
Gregory Ryslik is a statistician, data scientist and artificial intelligence researcher with experience building and leading data initiatives in companies across the biotech, autotech, healthtech and fintech domains.